"astellas" - Google News

Astellas Board Change Raises Questions On R&D Oversight And Governance - Yahoo Finance

Wed, 03 Jun 2026 10:07:09 GMT

Astellas Board Change Raises Questions On R&D Oversight And Governance Yahoo Finance

Facing looming Xtandi patent cliff, Astellas pins hopes on more deals while still cutting costs - Fierce Biotech

Tue, 26 May 2026 11:35:43 GMT

Facing looming Xtandi patent cliff, Astellas pins hopes on more deals while still cutting costs Fierce Biotech

Astellas Pharma: Five-year plan aims for record revenues, pipeline-driven growth, and major oncology advances - TradingView

Wed, 03 Jun 2026 13:39:18 GMT

Astellas Pharma: Five-year plan aims for record revenues, pipeline-driven growth, and major oncology advances TradingView

Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026 - PR Newswire

Mon, 18 May 2026 07:00:00 GMT

Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026 PR Newswire

Astellas’s R&D head talks strategy ahead of looming patent cliff - Chemical & Engineering News

Wed, 29 Apr 2026 07:00:00 GMT

Astellas’s R&D head talks strategy ahead of looming patent cliff Chemical & Engineering News

Biopharma bites: Astellas' five-year strategy, funding for Editas, Cartesian - FirstWord Pharma

Tue, 26 May 2026 23:19:23 GMT

Biopharma bites: Astellas' five-year strategy, funding for Editas, Cartesian FirstWord Pharma

Astellas eyes more cost cuts; FDA panel to debate Moderna vaccine - BioPharma Dive

Tue, 26 May 2026 14:39:27 GMT

Astellas eyes more cost cuts; FDA panel to debate Moderna vaccine BioPharma Dive

Astellas counts on new medicines to offset projected Xtandi decline in fiscal 2026 - Fierce Pharma

Mon, 27 Apr 2026 07:00:00 GMT

Astellas counts on new medicines to offset projected Xtandi decline in fiscal 2026 Fierce Pharma

Dyno Therapeutics Announces Capsid License Exercised by Astellas for Skeletal Muscle-Targeted Gene Delivery, Validating AI-Powered Technology for Biological Sequence Design - Business Wire

Wed, 08 Apr 2026 07:00:00 GMT

Dyno Therapeutics Announces Capsid License Exercised by Astellas for Skeletal Muscle-Targeted Gene Delivery, Validating AI-Powered Technology for Biological Sequence Design Business Wire

Astellas Pharma: Pipeline-led growth and margin expansion driven by strategic brands and disciplined investment - TradingView

Wed, 03 Jun 2026 13:06:03 GMT

Astellas Pharma: Pipeline-led growth and margin expansion driven by strategic brands and disciplined investment TradingView

Astellas thins early pipeline, swaps out struggling rare disease gene therapy - Fierce Biotech

Mon, 27 Apr 2026 07:00:00 GMT

Astellas thins early pipeline, swaps out struggling rare disease gene therapy Fierce Biotech

Astellas Announces Five-Year Corporate Strategic Plan to Deliver Greater VALUE Faster for Patients and Position Itself as a Sustainable Growth Company - PR Newswire

Tue, 26 May 2026 07:00:00 GMT

Astellas Announces Five-Year Corporate Strategic Plan to Deliver Greater VALUE Faster for Patients and Position Itself as a Sustainable Growth Company PR Newswire

Assessing Astellas Pharma (TSE:4503) Valuation After A Sharp Pullback And Strong One Year Return - Yahoo Finance

Sat, 02 May 2026 07:00:00 GMT

Assessing Astellas Pharma (TSE:4503) Valuation After A Sharp Pullback And Strong One Year Return Yahoo Finance

Fierce Pharma Asia—Astellas’ stem cell therapy rethink; GSK’s bullish ADC plan; Daiichi’s OTC sale - Fierce Pharma

Fri, 17 Apr 2026 07:00:00 GMT

Fierce Pharma Asia—Astellas’ stem cell therapy rethink; GSK’s bullish ADC plan; Daiichi’s OTC sale Fierce Pharma

Astellas to Highlight New Findings for Geographic Atrophy at ARVO 2026 Annual Meeting - PR Newswire

Thu, 30 Apr 2026 07:00:00 GMT

Astellas to Highlight New Findings for Geographic Atrophy at ARVO 2026 Annual Meeting PR Newswire

Astellas to close stem cell unit’s Seattle site, with layoffs incoming - Fierce Biotech

Tue, 14 Apr 2026 07:00:00 GMT

Astellas to close stem cell unit’s Seattle site, with layoffs incoming Fierce Biotech

Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer - PR Newswire

Mon, 23 Feb 2026 08:00:00 GMT

Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer PR Newswire

Chutes & Ladders—Astellas appoints new top strategist from Sanofi Japan - Fierce Biotech

Fri, 01 May 2026 07:00:00 GMT

Chutes & Ladders—Astellas appoints new top strategist from Sanofi Japan Fierce Biotech

Astellas axes early Sjögren’s trial in latest setback for autoimmune disease community - Fierce Biotech

Mon, 30 Mar 2026 07:00:00 GMT

Astellas axes early Sjögren’s trial in latest setback for autoimmune disease community Fierce Biotech

Astellas unearths Dyno muscle disorder AAV capsid with $15M option agreement - Fierce Biotech

Wed, 08 Apr 2026 07:00:00 GMT

Astellas unearths Dyno muscle disorder AAV capsid with $15M option agreement Fierce Biotech

Astellas Pharma awards DTC, HCP business to CMI, Compas and WPP Media - Medical Marketing and Media

Mon, 09 Mar 2026 07:00:00 GMT

Astellas Pharma awards DTC, HCP business to CMI, Compas and WPP Media Medical Marketing and Media

50 employees impacted as Astellas closes Universal Cells’ Seattle office - BioSpace

Tue, 14 Apr 2026 07:00:00 GMT

50 employees impacted as Astellas closes Universal Cells’ Seattle office BioSpace

Astellas Pharma Shares Fall After Unveiling Five-Year Plan - Bloomberg.com

Tue, 26 May 2026 07:00:00 GMT

Astellas Pharma Shares Fall After Unveiling Five-Year Plan Bloomberg.com

Astellas Says Newer Drugs Set to Drive Profit Growth by 2030 - Bloomberg.com

Tue, 26 May 2026 07:00:00 GMT

Astellas Says Newer Drugs Set to Drive Profit Growth by 2030 Bloomberg.com

A Look At Astellas Pharma’s Valuation After A Strong Year Of Share Price Gains - Yahoo Finance

Fri, 10 Apr 2026 07:00:00 GMT

A Look At Astellas Pharma’s Valuation After A Strong Year Of Share Price Gains Yahoo Finance

Astellas starts a second pivotal degrader trial | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Wed, 13 May 2026 07:00:00 GMT

Astellas starts a second pivotal degrader trial | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Astellas walks away from $1.6B biobucks T-cell engager pact with CytomX after 6 years - Fierce Biotech

Mon, 16 Mar 2026 07:00:00 GMT

Astellas walks away from $1.6B biobucks T-cell engager pact with CytomX after 6 years Fierce Biotech

Fierce Pharma Asia—More China biotech hawkishness; Pfizer’s $10B Innovent deal; Astellas’ roadmap - Fierce Pharma

Fri, 29 May 2026 12:30:00 GMT

Fierce Pharma Asia—More China biotech hawkishness; Pfizer’s $10B Innovent deal; Astellas’ roadmap Fierce Pharma

Astellas Divorces CytomX Despite Positive Phase 1 Data for Antibody Platform - BioSpace

Tue, 17 Mar 2026 07:00:00 GMT

Astellas Divorces CytomX Despite Positive Phase 1 Data for Antibody Platform BioSpace

Astellas Takes Aim at XLMTM Again, Now with MyoAAV Capsid-Based Gene Therapy - Genetic Engineering and Biotechnology News

Tue, 20 Jan 2026 08:00:00 GMT

Astellas Takes Aim at XLMTM Again, Now with MyoAAV Capsid-Based Gene Therapy Genetic Engineering and Biotechnology News

Astellas Bets up to $1.7B for Vir’s ‘Robust Competitor’ in Prostate Cancer - BioSpace

Tue, 24 Feb 2026 08:00:00 GMT

Astellas Bets up to $1.7B for Vir’s ‘Robust Competitor’ in Prostate Cancer BioSpace

Astellas Pharmaceuticals Enters $1.7 Billion Global Collaboration with Vir Biotechnology to advance PSMA-targeting PRO-XTEN - Pharmaceutical Executive

Tue, 24 Feb 2026 08:00:00 GMT

Astellas Pharmaceuticals Enters $1.7 Billion Global Collaboration with Vir Biotechnology to advance PSMA-targeting PRO-XTEN Pharmaceutical Executive

Astellas manufacturing chief views reliable supply, bridging research as his production 'north star' - Fierce Pharma

Wed, 15 Apr 2026 07:00:00 GMT

Astellas manufacturing chief views reliable supply, bridging research as his production 'north star' Fierce Pharma

Astellas Licenses Dyno Therapeutics’ AI-Designed AAV Capsid, Advancing Gene Delivery for Muscle Disorders - BioPharm International

Fri, 10 Apr 2026 07:00:00 GMT

Astellas Licenses Dyno Therapeutics’ AI-Designed AAV Capsid, Advancing Gene Delivery for Muscle Disorders BioPharm International

'The perfect partner': Astellas, Vir engage in $1.7B deal for masked prostate cancer bispecific - Fierce Biotech

Mon, 23 Feb 2026 08:00:00 GMT

'The perfect partner': Astellas, Vir engage in $1.7B deal for masked prostate cancer bispecific Fierce Biotech

Astellas’ “strategic brands” and “primary focuses” after XTANDI - Labiotech.eu

Mon, 27 Apr 2026 07:00:00 GMT

Astellas’ “strategic brands” and “primary focuses” after XTANDI Labiotech.eu

Astellas Announces Top Management Personnel Change - PR Newswire

Mon, 29 Sep 2025 07:00:00 GMT

Astellas Announces Top Management Personnel Change PR Newswire

Astellas To Present New Data on XOSPATA™ (gilteritinib) Across the FLT3m+ AML Disease Continuum at ASH 2025 Annual Meeting - PR Newswire

Fri, 05 Dec 2025 08:00:00 GMT

Astellas To Present New Data on XOSPATA™ (gilteritinib) Across the FLT3m+ AML Disease Continuum at ASH 2025 Annual Meeting PR Newswire

Astellas treatment offers new hope to a devastated rare disease community - statnews.com

Mon, 11 May 2026 07:00:00 GMT

Astellas treatment offers new hope to a devastated rare disease community statnews.com

Pfizer Inc. (PFE) and Astellas Pharma Announce Positive Results From the Phase 3 EV-304 Clinical Trial for PADCEVTM - Yahoo Finance

Sun, 01 Mar 2026 08:00:00 GMT

Pfizer Inc. (PFE) and Astellas Pharma Announce Positive Results From the Phase 3 EV-304 Clinical Trial for PADCEVTM Yahoo Finance

Fierce Pharma Asia—World's 1st brain chip nod; AZ's cell therapy bet; Astellas-CytomX breakup - Fierce Pharma

Fri, 20 Mar 2026 07:00:00 GMT

Fierce Pharma Asia—World's 1st brain chip nod; AZ's cell therapy bet; Astellas-CytomX breakup Fierce Pharma

Evinova Announces Strategic Collaborations with Astellas, AstraZeneca and Bristol Myers Squibb Advancing Its AI-Native Platform to Accelerate Global Clinical Development - Business Wire

Wed, 18 Feb 2026 08:00:00 GMT

Evinova Announces Strategic Collaborations with Astellas, AstraZeneca and Bristol Myers Squibb Advancing Its AI-Native Platform to Accelerate Global Clinical Development Business Wire

Evinova reels in AI clinical development deals with Astellas and AstraZeneca - Fierce Biotech

Tue, 24 Feb 2026 08:00:00 GMT

Evinova reels in AI clinical development deals with Astellas and AstraZeneca Fierce Biotech

Astellas tops expectations as Vyloy sales surge outshines trial setback - Fierce Pharma

Thu, 05 Feb 2026 08:00:00 GMT

Astellas tops expectations as Vyloy sales surge outshines trial setback Fierce Pharma

Astellas collaborates with Vir to develop its experimental prostate cancer drug - Reuters

Mon, 23 Feb 2026 08:00:00 GMT

Astellas collaborates with Vir to develop its experimental prostate cancer drug Reuters

Astellas retries XLMTM gene therapy after deaths - statnews.com

Mon, 27 Apr 2026 07:00:00 GMT

Astellas retries XLMTM gene therapy after deaths statnews.com

Astellas to Present at 44th Annual J.P. Morgan Healthcare Conference - PR Newswire

Tue, 06 Jan 2026 08:00:00 GMT

Astellas to Present at 44th Annual J.P. Morgan Healthcare Conference PR Newswire

Astellas Pharma closes 6 datacenters worldwide by moving to Azure with Azure Data Box - Microsoft

Wed, 03 Sep 2025 07:00:00 GMT

Astellas Pharma closes 6 datacenters worldwide by moving to Azure with Azure Data Box Microsoft

Is Astellas Pharma (ALPMY) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Wed, 25 Mar 2026 07:00:00 GMT

Is Astellas Pharma (ALPMY) Outperforming Other Medical Stocks This Year? Yahoo Finance

Astellas CEO talks transformative medicines driving growth - statnews.com

Mon, 23 Feb 2026 08:00:00 GMT

Astellas CEO talks transformative medicines driving growth statnews.com

Fierce Pharma Asia—Astellas CEO's BD plan; Takeda's US layoffs; Chugai's chase for name recognition - Fierce Pharma

Fri, 23 Jan 2026 08:00:00 GMT

Fierce Pharma Asia—Astellas CEO's BD plan; Takeda's US layoffs; Chugai's chase for name recognition Fierce Pharma

Fierce Pharma Asia—Sun’s $11.75B Organon buy; Astellas’ Xtandi peak; BeOne’s PD-1xVEGF bet - Fierce Pharma

Fri, 01 May 2026 07:00:00 GMT

Fierce Pharma Asia—Sun’s $11.75B Organon buy; Astellas’ Xtandi peak; BeOne’s PD-1xVEGF bet Fierce Pharma

JPM26: Astellas CEO resists 'rescue BD' as $6B Xtandi patent cliff nears - Fierce Pharma

Thu, 15 Jan 2026 08:00:00 GMT

JPM26: Astellas CEO resists 'rescue BD' as $6B Xtandi patent cliff nears Fierce Pharma

How Attractive Is Astellas Pharma After a 44.1% Surge and Mixed Valuation Signals? - Yahoo Finance

Mon, 22 Dec 2025 08:00:00 GMT

How Attractive Is Astellas Pharma After a 44.1% Surge and Mixed Valuation Signals? Yahoo Finance

Astellas casts retina specialists as 'Partners in Protection' in Izervay HCP campaign - Fierce Pharma

Fri, 13 Feb 2026 08:00:00 GMT

Astellas casts retina specialists as 'Partners in Protection' in Izervay HCP campaign Fierce Pharma

Vir climbs on Astellas deal, study results for ‘masked’ T cell engager - BioPharma Dive

Tue, 24 Feb 2026 08:00:00 GMT

Vir climbs on Astellas deal, study results for ‘masked’ T cell engager BioPharma Dive

Redefining Precision Oncology: Astellas’ Vision for Transformative Cancer Care - Fierce Pharma

Mon, 13 Oct 2025 07:00:00 GMT

Redefining Precision Oncology: Astellas’ Vision for Transformative Cancer Care Fierce Pharma

Astellas to Present New Data on IZERVAY™ (avacincaptad pegol intravitreal solution) in Geographic Atrophy at AAO 2025 Annual Meeting - PR Newswire

Wed, 08 Oct 2025 07:00:00 GMT

Astellas to Present New Data on IZERVAY™ (avacincaptad pegol intravitreal solution) in Geographic Atrophy at AAO 2025 Annual Meeting PR Newswire

Astellas to Present New Clinical Data Across Its Gastrointestinal Cancers Portfolio at 2026 ASCO GI Cancers Symposium - PR Newswire

Wed, 10 Dec 2025 08:00:00 GMT

Astellas to Present New Clinical Data Across Its Gastrointestinal Cancers Portfolio at 2026 ASCO GI Cancers Symposium PR Newswire

Why Vir Biotechnology (VIR) Is Down 5.1% After Astellas Oncology Deal And Brii Arbitration - Yahoo Finance

Wed, 29 Apr 2026 07:00:00 GMT

Why Vir Biotechnology (VIR) Is Down 5.1% After Astellas Oncology Deal And Brii Arbitration Yahoo Finance

Astellas To Present Pioneering Advances Across Its Portfolio and Pipeline at ESMO 2025 - PR Newswire

Wed, 01 Oct 2025 07:00:00 GMT

Astellas To Present Pioneering Advances Across Its Portfolio and Pipeline at ESMO 2025 PR Newswire

A Look At Vir Biotechnology (VIR) Valuation After The Astellas Partnership And Pipeline Progress - Yahoo Finance

Sat, 09 May 2026 07:00:00 GMT

A Look At Vir Biotechnology (VIR) Valuation After The Astellas Partnership And Pipeline Progress Yahoo Finance

Tokyo pharma company to close Seattle office, lay off dozens of employees - The Business Journals

Mon, 13 Apr 2026 07:00:00 GMT

Tokyo pharma company to close Seattle office, lay off dozens of employees The Business Journals

India's Zydus Life agrees $120 million settlement with Astellas over bladder drug - Reuters

Thu, 12 Feb 2026 08:00:00 GMT

India's Zydus Life agrees $120 million settlement with Astellas over bladder drug Reuters

Astellas, Vir Biotechnology Launch Up-to-$1.7B Prostate Cancer Collaboration - Genetic Engineering and Biotechnology News

Wed, 25 Feb 2026 08:00:00 GMT

Astellas, Vir Biotechnology Launch Up-to-$1.7B Prostate Cancer Collaboration Genetic Engineering and Biotechnology News

Astellas Presents Preliminary Real-World VEOZAH™ (fezolinetant) Data From OPTION-VMS Phase IV Observational Study - PR Newswire

Wed, 22 Oct 2025 07:00:00 GMT

Astellas Presents Preliminary Real-World VEOZAH™ (fezolinetant) Data From OPTION-VMS Phase IV Observational Study PR Newswire

Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Fri, 10 Apr 2026 07:00:00 GMT

Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year? Yahoo Finance

Astellas Scraps Up-to-$1.7B CytomX Cancer Immunotherapy Collaboration - Genetic Engineering and Biotechnology News

Tue, 17 Mar 2026 07:00:00 GMT

Astellas Scraps Up-to-$1.7B CytomX Cancer Immunotherapy Collaboration Genetic Engineering and Biotechnology News

Astellas Headed to Trial in Deal Case Worth Up to $115 Million - Bloomberg Law News

Wed, 01 Apr 2026 07:00:00 GMT

Astellas Headed to Trial in Deal Case Worth Up to $115 Million Bloomberg Law News

Five years after disaster, a rare disease community gets new chance at treatment - statnews.com

Mon, 11 May 2026 07:00:00 GMT

Five years after disaster, a rare disease community gets new chance at treatment statnews.com

Astellas Wins Patent Ruling Blocking Ascent’s Myrbetriq Copies - Bloomberg Law News

Tue, 10 Mar 2026 07:00:00 GMT

Astellas Wins Patent Ruling Blocking Ascent’s Myrbetriq Copies Bloomberg Law News

Fierce Pharma Asia—China deal growth; Daiichi's new CMO; Astellas-Vir bispecific tie-up - Fierce Pharma

Fri, 27 Feb 2026 08:00:00 GMT

Fierce Pharma Asia—China deal growth; Daiichi's new CMO; Astellas-Vir bispecific tie-up Fierce Pharma

Astellas walks away from gene therapy pact with Taysha before pivotal trial launch - Fierce Biotech

Fri, 17 Oct 2025 07:00:00 GMT

Astellas walks away from gene therapy pact with Taysha before pivotal trial launch Fierce Biotech

Astellas Beats $115M Milestone Claim In Del. Chancery Ruling - Law360

Wed, 01 Apr 2026 07:00:00 GMT

Astellas Beats $115M Milestone Claim In Del. Chancery Ruling Law360

India's Zydus Life agrees $120 million settlement with Astellas over bladder drug - Yahoo Finance

Thu, 12 Feb 2026 08:00:00 GMT

India's Zydus Life agrees $120 million settlement with Astellas over bladder drug Yahoo Finance

A Look At Astellas Pharma (TSE:4503) Valuation As New Oncology Data Approaches ASCO 2026 - simplywall.st

Tue, 19 May 2026 07:00:00 GMT

A Look At Astellas Pharma (TSE:4503) Valuation As New Oncology Data Approaches ASCO 2026 simplywall.st

Aviceda geographic atrophy hopeful fails to top Astellas' med in phase 2 - Fierce Biotech

Mon, 15 Dec 2025 08:00:00 GMT

Aviceda geographic atrophy hopeful fails to top Astellas' med in phase 2 Fierce Biotech

Fierce Pharma Asia—A trio of Lilly investments; Pfizer, Sciwind's GLP-1 nod; Astellas' MFN windfall - Fierce Pharma

Fri, 13 Mar 2026 07:00:00 GMT

Fierce Pharma Asia—A trio of Lilly investments; Pfizer, Sciwind's GLP-1 nod; Astellas' MFN windfall Fierce Pharma

Ocugen posts midphase gene therapy data, charting course for rivalry with Apellis, Astellas - Fierce Biotech

Thu, 15 Jan 2026 08:00:00 GMT

Ocugen posts midphase gene therapy data, charting course for rivalry with Apellis, Astellas Fierce Biotech

Astellas and the Internet's Favorite Grandma, Barbara 'Babs' Costello, Partner to Encourage Others to Get Ahead of Geographic Atrophy (GA) - PR Newswire

Thu, 23 Oct 2025 07:00:00 GMT

Astellas and the Internet's Favorite Grandma, Barbara 'Babs' Costello, Partner to Encourage Others to Get Ahead of Geographic Atrophy (GA) PR Newswire

Trump’s drug cost push helps Astellas win higher price in Japan - The Japan Times

Wed, 11 Mar 2026 07:00:00 GMT

Trump’s drug cost push helps Astellas win higher price in Japan The Japan Times

Autobahn Labs Forms Strategic Partnership with Astellas to Accelerate Academic Discoveries into New Medicines - GlobeNewswire

Thu, 11 Dec 2025 08:00:00 GMT

Autobahn Labs Forms Strategic Partnership with Astellas to Accelerate Academic Discoveries into New Medicines GlobeNewswire

Vir Biotechnology Astellas Deal Puts VIR-5500 And Valuation In Focus - Yahoo Finance

Sat, 28 Feb 2026 08:00:00 GMT

Vir Biotechnology Astellas Deal Puts VIR-5500 And Valuation In Focus Yahoo Finance

Trump’s Drug Cost Push Helps Astellas Win Higher Price in Japan - Bloomberg Law News

Tue, 10 Mar 2026 07:00:00 GMT

Trump’s Drug Cost Push Helps Astellas Win Higher Price in Japan Bloomberg Law News

Vir–Astellas Prostate Cancer Deal and ALX Oncology’s 2025 Results Set 2026 Catalysts - Oncodaily

Sat, 28 Feb 2026 08:00:00 GMT

Vir–Astellas Prostate Cancer Deal and ALX Oncology’s 2025 Results Set 2026 Catalysts Oncodaily

Astellas Announces Five-Year Corporate Strategic Plan to Deliver Greater VALUE Faster for Patients and Position Itself as a Sustainable Growth Company – Company Announcement - Financial Times

Tue, 26 May 2026 06:45:00 GMT

Astellas Announces Five-Year Corporate Strategic Plan to Deliver Greater VALUE Faster for Patients and Position Itself as a Sustainable Growth Company – Company Announcement Financial Times

Astellas Bets On Degradation Over Inhibition In Race To Crack KRAS G12D - Citeline News & Insights

Mon, 16 Mar 2026 07:00:00 GMT

Astellas Bets On Degradation Over Inhibition In Race To Crack KRAS G12D Citeline News & Insights

How Astellas’ CFO weighs cash management, leadership and ‘nomikai’ culture - CFO.com

Tue, 02 Dec 2025 08:00:00 GMT

How Astellas’ CFO weighs cash management, leadership and ‘nomikai’ culture CFO.com

Astellas to Present First Real-World VEOZAH™ (fezolinetant) Data at 2025 Annual Meeting of The Menopause Society - PR Newswire

Tue, 14 Oct 2025 07:00:00 GMT

Astellas to Present First Real-World VEOZAH™ (fezolinetant) Data at 2025 Annual Meeting of The Menopause Society PR Newswire

Vir Biotech Catapults On Its $1.71 Billion Deal With Astellas - Investor's Business Daily

Tue, 24 Feb 2026 08:00:00 GMT

Vir Biotech Catapults On Its $1.71 Billion Deal With Astellas Investor's Business Daily

Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer - BioSpace

Fri, 17 Apr 2026 07:00:00 GMT

Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer BioSpace

Earnings call transcript: Astellas Pharma Q3 2025 sees revenue boost, stock rises - Investing.com

Wed, 04 Feb 2026 08:00:00 GMT

Earnings call transcript: Astellas Pharma Q3 2025 sees revenue boost, stock rises Investing.com

Pfizer, Astellas Report Positive Phase 3 Trial Results for PADCEV Combination in Bladder Cancer Treatment - Yahoo Finance

Thu, 08 Jan 2026 08:00:00 GMT

Pfizer, Astellas Report Positive Phase 3 Trial Results for PADCEV Combination in Bladder Cancer Treatment Yahoo Finance

Astellas-Pfizer's combination therapy halves risk of death in bladder cancer patients - Reuters

Sat, 18 Oct 2025 07:00:00 GMT

Astellas-Pfizer's combination therapy halves risk of death in bladder cancer patients Reuters

Lupin Agrees to Pay Astellas $90 Million in Drug Patent Dispute - Bloomberg Law News

Tue, 10 Feb 2026 08:00:00 GMT

Lupin Agrees to Pay Astellas $90 Million in Drug Patent Dispute Bloomberg Law News

Astellas suffers pancreatic cancer failure with Vyloy - pharmaphorum

Tue, 14 Oct 2025 07:00:00 GMT

Astellas suffers pancreatic cancer failure with Vyloy pharmaphorum

Astellas taps social media star Babs Costello to promote Izervay for geographic atrophy - Fierce Pharma

Thu, 23 Oct 2025 07:00:00 GMT

Astellas taps social media star Babs Costello to promote Izervay for geographic atrophy Fierce Pharma

Astellas' Vyloy misses OS goal in Phase II pancreatic cancer study - FirstWord Pharma

Tue, 14 Oct 2025 07:00:00 GMT

Astellas' Vyloy misses OS goal in Phase II pancreatic cancer study FirstWord Pharma

India's Lupin settles US patent dispute with Astellas Pharma for $90 million - Yahoo Finance

Mon, 09 Feb 2026 08:00:00 GMT

India's Lupin settles US patent dispute with Astellas Pharma for $90 million Yahoo Finance

India's Lupin clears patent hurdle with Astellas Pharma, keeps Mirabegron sales in US - Yahoo! Finance Canada

Mon, 09 Feb 2026 08:00:00 GMT

India's Lupin clears patent hurdle with Astellas Pharma, keeps Mirabegron sales in US Yahoo! Finance Canada